Conference Day Two

**This Event Has Now Run**

7:30 am
Morning Networking Coffee

8:15 am Chair’s Opening Remarks

  • Andreas Kuhn Senior Vice President RNA Biochemistry & Manufacturing, RNA Biochemistry & Manufacturing, BioNTech

Understanding the Regulatory Path for Established & Emerging mRNA Technologies

8:30 am An Exclusive Overview of the Regulatory Environment & Regulatory Strategy for mRNA Vaccines

Synopsis

For more information on this session, please download the full event guide.

9:00 am Is “GMP Grade” Good Enough? Choosing Materials for Producing mRNA Therapeutics

  • Darwin Asa Global Market Development Manager, Nucleic Acid Therapeutics, , Thermo Fisher

Synopsis

For more information on this session, please download the full event guide.

9:30 am Utilising mRNA Gene Editing Techniques to Engineer Novel NK Cells & Overcome Regulatory Hurdles

  • Aviad Pato Head of Research & Natural Killer Cells, Gamida Cell

Synopsis

For more information on this session, please download the full event guide.

10:00 am Navigating the Challenges & Opportunities in mRNA Drug Product Manufacturing

  • May Guo Vice President, Nucleic Acids, Arranta Bio

Synopsis

For more information on this session, please download the full event guide.

10:30 am
Morning Refreshment Break & Poster Session

1:00 pm
Networking Lunch Break

From Discovery to Clinical Development: Paving the Path Forward for Better Clinical Translation

2:00 pm Panel Discussion: How to Streamline Practices for mRNA- Based Therapeutics Across the Development Value Chain & Overcome Key Bottlenecks for Better Clinical Translation

  • Andreas Kuhn Senior Vice President RNA Biochemistry & Manufacturing, RNA Biochemistry & Manufacturing, BioNTech
  • Gregory Fiore Co-Founder & Chief Executive Officer, Exacis Biotherapeutics
  • Nagy Habib Head of Surgery Hammersmith Campus , Imperial College London

Synopsis

For more information on this session, please download the full event guide.

Developing Tomorrow’s mRNA-Based Therapies

2:30 pm Optimizing mRNA Manufacturing: Take control of your mRNA process along the chain

3:00 pm Assessing Synthetic Circular RNA (oRNATM) as a New Therapeutic Modality

  • Nelson Chau Senior Vice President - Platform, Orna Therapeutics

Synopsis

For more information on this session, please download the full event guide.

3:30 pm
Chair’s Closing Remarks & End of 2nd Annual mRNA-Based Therapeutics Summit Europe 2023

  • Andreas Kuhn Senior Vice President RNA Biochemistry & Manufacturing, RNA Biochemistry & Manufacturing, BioNTech